Skip to main content

Advertisement

SpringerLink
Log in

Proline protects liver from d-galactosamine hepatitis by activating the IL-6/STAT3 survival signaling pathway

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

The oral administration of proline, one of the non-essential amino acids, has been shown to effectively protect the liver from d-galactosamine (GalN)-induced liver injury and to improve the survival rate. The aim of this study was to investigate the mechanism of this protective action of proline. We paid particular attention to the effect of proline on inflammatory activation, regenerative response, and the associated signal transduction in the liver. Male Fischer rats received intraperitoneal injections of GalN (1.4 g/kg) with or without the oral administration of proline (2 g/kg) 1 h before GalN treatment. Liver pathology, plasma indices of inflammation, and the level of proliferative marker in the liver were monitored. The hepatic activation of interleukin-6 (IL-6)/signal transducer and activator of transcription (STAT)-3 pathway, which is downstream of tumor necrosis factor (TNF)-α/nuclear factor-κB, was also studied. GalN induced massive inflammatory expansion in the liver, leading to a high death rate (60 %) more than 72 h after the treatment. Proline administration significantly suppressed inflammatory infiltration in the live after 48 h, which was accompanied by depletion of plasma TNF-α, glutamic oxaloacetic transaminase, and glutamic pyruvic transaminase. The mRNA expression of histone H3, a marker of proliferation, was significantly upregulated in the liver of proline-treated animals. Furthermore, IL-6/STAT-3 pathway, an anti-inflammatory and regenerative signaling pathway, was strongly activated prior to these observations, with the upregulated expression of downstream genes. These results suggest that the tissue-protective mechanism of proline involves the early activation of IL-6/STAT-3 pathway in the liver, with subsequent activation of the regenerative response and suppression of massive inflammatory activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

GalN:

d-Galactosamine

IL-6:

Interleukin-6

STAT3:

Signal transducer and activator of transcription 3

TNF-α:

Tumor necrosis factor-α

NF-κB:

Nuclear factor kappa B

GOT:

Glutamic oxaloacetic transaminase

GPT:

Glutamic pyruvic transaminase

LEC rat:

Long Evans Cinnamon rat

SDS:

Sodium dodecyl sulfate

XIAP:

X-chromosome-linked inhibitor of apoptosis

MAPK:

Mitogen-activated protein kinase kinase

FLIP:

FLICE-inhibitory protein

ROS:

Reactive oxygen species

POX:

Proline oxidase

FAD:

Flavine adenine dinucleotide

References

  • Adams E, Frank L (1980) Metabolism of proline and the hydroxyprolines. Annu Rev Biochem 49:1005–1061. doi:10.1146/annurev.bi.49.070180.005041

    Article  PubMed  CAS  Google Scholar 

  • Ajinomoto Co., Inc. (1996) Japan Patent Kokai 1996-169063

  • Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X et al (2002) Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 35:40–48. doi:10.1053/jhep2002.30081

    Article  PubMed  CAS  Google Scholar 

  • Chen Lf, Fischle W, Verdin E, Greene WC (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293:1653–1657. doi:10.1126/science.1062374

    Article  CAS  Google Scholar 

  • Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V et al (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379–1383. doi:10.1126/science.274.5291.1379

    Article  PubMed  CAS  Google Scholar 

  • Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D et al (2001) Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res 61:1810–1815

    PubMed  CAS  Google Scholar 

  • Fujiyoshi M, Ozaki M (2011) Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J Hepatobiliary Pancreat Sci 18(1):13–22

    Article  PubMed  Google Scholar 

  • Gloire G, Legrand-Poels S, Piette J (2006) NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72:1493–1505. doi:10.1016/j.bcp.2006.04.011

    Article  PubMed  CAS  Google Scholar 

  • Grün M, Liehr H, Rasenack U (1977) Significance of endotoxaemia in experimental “galactosamine-hepatitis” in the rat. Acta Hepatogastroenterol (Stuttg) 24:64–81

    Google Scholar 

  • Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H et al (2003) Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 112:989–998. doi:10.1172/JCI200317970

    PubMed  CAS  Google Scholar 

  • Hagedorn CH, Phang JM (1983) Transfer of reducing equivalents into mitochondria by the interconversions of proline and delta 1-pyrroline-5-carboxylate. Arch Biochem Biophys 225:95–101. doi:10.1016/0003-9861(83)90010-3

    Article  PubMed  CAS  Google Scholar 

  • Hawkins RL, Mori M, Inoue M, Torii K (1995) Proline, ascorbic acid, or thioredoxin affect jaundice and mortality in Long Evans cinnamon rats. Pharmacol Biochem Behav 52:509–515. doi:10.1016/0091-3057(95)00118-G

    Article  PubMed  CAS  Google Scholar 

  • Itokazu Y, Segawa Y, Inoue N, Omata T (1999) D-galactosamine-induced mouse hepatic apoptosis: possible involvement with tumor necrosis factor, but not with caspase-3 activity. Biol Pharm Bull 22:1127–1130

    Article  PubMed  CAS  Google Scholar 

  • Jirillo E, Caccavo D, Magrone T, Piccigallo E, Amati L, Lembo A et al (2002) The role of the liver in the response to LPS: experimental and clinical findings. J Endotoxin Res 8:319–327. doi:10.1177/09680519020080050501

    PubMed  CAS  Google Scholar 

  • Kirillova I, Chaisson M, Fausto N (1999) Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ 10:819–828

    PubMed  CAS  Google Scholar 

  • Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R (2000) Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31:149–159. doi:10.1002/hep510310123

    Article  PubMed  CAS  Google Scholar 

  • Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R (2001) Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276:26605–26613. doi:10.1074/jbc.M100740200

    Article  PubMed  CAS  Google Scholar 

  • Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z et al (2009) Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15:283–293. doi:10.1016/j.ccr.2009.02.015

    Article  PubMed  CAS  Google Scholar 

  • Li W, Liang X, Kellendonk C, Poli V, Taub R (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411–28417. doi:10.1074/jbc.M202807200

    Article  PubMed  CAS  Google Scholar 

  • Li W, Liang X, Leu JI, Kovalovich K, Ciliberto G, Taub R (2001) Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 33:1377–1386. doi:10.1053/jhep2001.24431

    Article  PubMed  CAS  Google Scholar 

  • MacDonald JR, Beckstead JH, Smuckler EA (1987) An ultrastructural and histochemical study of the prominent inflammatory response in d (+)-galactosamine hepatotoxicity. Br J Exp Pathol 68:189–199

    PubMed  CAS  Google Scholar 

  • Matsumoto T, O’Malley K, Efron PA, Burger C, McAuliffe PF, Scumpia PO et al (2006) Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 140:793–802. doi:10.1016/j.surg.2006.04.010

    Article  PubMed  Google Scholar 

  • Moh A, Iwamoto Y, Chai GX, Zhang SS, Kano A, Yang DD et al (2007) Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest 87:1018–1028. doi:10.1038/labinvest.3700630

    Article  PubMed  CAS  Google Scholar 

  • Phang JM (1985) The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr Top Cell Regul 25:91–132

    PubMed  CAS  Google Scholar 

  • Schuringa JJ, Dekker LV, Vellenga E, Kruijer W (2001) Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase Cdelta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation. J Biol Chem 276(29):27709–27715. doi:10.1074/jbc.M009821200

    Article  PubMed  CAS  Google Scholar 

  • Singh A, Jayaraman A, Hahn J (2006) Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes. Biotechnol Bioeng 95(5):850–862. doi:10.1002/bit.21026

    Article  PubMed  CAS  Google Scholar 

  • Teoh N, Leclercq I, Pena AD, Farrell G (2003) Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 37(1):118–128. doi:10.1053/jhep2003.50009

    Article  PubMed  CAS  Google Scholar 

  • Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I et al (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39–49. doi:10.1016/S1074-7613(00)80005-9

    Article  PubMed  CAS  Google Scholar 

  • Taub R (2003) Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest 112:978–980. doi:10.1172/JCI200319974

    PubMed  CAS  Google Scholar 

  • Wu G, Bazer FW, Burghardt RC, Johnson GA, Kim SW, Knabe DA, Li P, Li X, McKnight JR, Satterfield MC, Spencer TE (2011) Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids 40(4):1053–1063. doi:10.1007/s00726-010-0715-z

    Article  PubMed  CAS  Google Scholar 

  • Vemura RP, Aragona E, Gupta S (1992) Analysis of hepatocelluar proliferation: study of archival liver tissue is facilitated by an endogenous marker of DNA replication. Hepatology 16:968–973

    Article  Google Scholar 

  • Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A et al (1998) NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol 275(4 Pt 1):C1058–C1066

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a private fund from Ajinomoto Co., Inc. The authors thank Dr. Koichi Ishii, Mr. Katsunori Kobayashi, Dr. Ikuko Sasahara, D.V.M., and Ms. Miwako Yamanoue for technical assistance and significant support.

Conflict of interest

This study was supported by a private fund from Ajinomoto Co., Inc. All authors are employee of Ajinomoto Co., Inc., which has published a large number of papers about the function of amino acids, strenuously doing basic research. No patent has been applied based on the research of this manuscript.

Author information

Author notes

  1. Yoko Obayashi

    Present address: , 1-15-1, Kyobashi, Chuo-ku, Tokyo, 104-8315, Japan

Authors and Affiliations

  1. Research Institute for Health Fundamentals, Ajinomoto Co., Inc, 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki, Kanagawa, 210-8681, Japan

    Yoko Obayashi, Harumi Arisaka, Shintaro Yoshida, Masato Mori & Michio Takahashi

Authors
  1. Yoko Obayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harumi Arisaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shintaro Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masato Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michio Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoko Obayashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Obayashi, Y., Arisaka, H., Yoshida, S. et al. Proline protects liver from d-galactosamine hepatitis by activating the IL-6/STAT3 survival signaling pathway. Amino Acids 43, 2371–2380 (2012). https://doi.org/10.1007/s00726-012-1317-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-012-1317-8

Keywords

Search

Navigation